Literature DB >> 17531960

Regarding "Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system".

David A Gorelick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17531960      PMCID： PMC1994814          DOI： 10.1016/j.biopsych.2007.01.019

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  8 in total

1.  Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats.

Authors:  Kabirullah Lutfy; Imran Khaliq; F Ivy Carroll; Nigel T Maidment
Journal:  Psychopharmacology (Berl)       Date:  2002-08-30       Impact factor: 4.530

2.  Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats.

Authors:  K Lutfy; T Do; N T Maidment
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

3.  Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference.

Authors:  J Kotlińska; J Wichmann; A Legowska; K Rolka; J Silberring
Journal:  Behav Pharmacol       Date:  2002-05       Impact factor: 2.293

4.  Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.

Authors:  Roberto Ciccocioppo; Daina Economidou; Roberto Rimondini; Wolfgang Sommer; Maurizio Massi; Markus Heilig
Journal:  Biol Psychiatry       Date:  2006-03-14       Impact factor: 13.382

Review 5.  Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.

Authors:  P A Compton; W Ling; V C Charuvastra; D R Wesson
Journal:  J Addict Dis       Date:  1995

6.  Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans.

Authors:  R S Schottenfeld; J Pakes; D Ziedonis; T R Kosten
Journal:  Biol Psychiatry       Date:  1993 Jul 1-15       Impact factor: 13.382

7.  Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.

Authors:  Ivan D Montoya; David A Gorelick; Kenzie L Preston; Jennifer R Schroeder; Annie Umbricht; Lawrence J Cheskin; W Robert Lange; Carlo Contoreggi; Rolley E Johnson; Paul J Fudala
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

8.  Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.

Authors:  Kazuto Sakoori; Niall P Murphy
Journal:  Psychopharmacology (Berl)       Date:  2003-11-18       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.